Children With ADHD Have Measurably Different Pupil Patterns, Study Finds
Your pupils do more than react to light: they quietly log your brain's moment-to-moment effort, arousal, and focus. A new study suggests those logs look meaningfully different in children with ADHD.
If you have ever wondered whether ADHD leaves any kind of physical trace that goes beyond behavior checklists and teacher questionnaires, early research out of India points to a surprising candidate: the way a child's pupils fluctuate from one moment to the next. A small but carefully designed study published in Scientific Reports found that unmedicated children with ADHD showed 23% greater trial-to-trial pupil response variability compared to neurotypical peers during a memory task. It is preliminary, and it is not ready for a clinic, but the signal is worth understanding.
Key takeaways:
- Unmedicated children with ADHD showed 23% more variability in how their pupils responded across repeated cognitive trials.
- Higher pupil variability correlated with lower task accuracy in the ADHD group.
- Medication (methylphenidate) brought pupil response patterns closer to those seen in the control group.
- This is early-stage research on a small sample; it cannot yet be used as a diagnostic tool.
Pupil Response Variability as a Potential ADHD Marker
Researchers from the Indraprastha Institute of Information Technology Delhi found that what sets children with ADHD apart is not simply the average size of their pupils, but how consistently their pupils respond across repeated cognitive demands. Pupil diameter is an indirect measure of activity in the locus coeruleus (a brainstem region that regulates arousal and attention through the neurotransmitter norepinephrine): when cognitive load rises, pupils typically dilate. The new finding is that in unmedicated children with ADHD, those dilations were far less predictable from one trial to the next, even when the task stayed the same.
This matters because most previous pupillometry research in ADHD tracked average pupil size or average dilation. Lead researcher Saumya Yadav noted that "looking at how pupil responses vary from trial to trial may provide information that is missed when we only look at average pupil size or behavioral performance." The variability itself, not just the magnitude, appears to carry signal. Separately, a multimodal study in PLOS Mental Health also found that combining pupil diameter measures with eye movement complexity improved diagnostic accuracy in ADHD, suggesting the field is converging on the idea that no single pupil metric tells the whole story.
Why Children With ADHD and Their Families Should Pay Attention
For a child currently being evaluated for ADHD, or a parent trying to make sense of an existing diagnosis, this line of research matters because it points toward objective, physiological anchors for a condition that is still diagnosed almost entirely through behavior ratings and clinical interviews. There is no blood test, no brain scan in routine use, no single definitive marker. That gap has real consequences: research on ADHD treatment biomarkers highlights how the absence of reliable physiological markers makes it harder to match individual patients to the treatments most likely to work for them.
Pupil-based measures will not fill that gap tomorrow. But if variability in pupil response turns out to be a consistent signature of disrupted attention regulation, it could eventually complement behavioral assessment in ways that make evaluations faster and more objective, particularly for children who struggle to sit through lengthy neuropsychological batteries.
How the Study Was Designed
The researchers reanalyzed existing eye-tracking data from 50 children aged 10 to 12 recruited in Chile. The group included 28 children with combined-type ADHD (the form involving both inattention and hyperactivity) and 22 neurotypically developing controls. Children played a spatial memory game: they watched a dot appear in a location, then saw a distracting image, then tried to recall where the dot had been. Pupil diameter was sampled 1,000 times per second across 160 trials per child, generating a dense record of arousal fluctuations.
A sub-study tracked 17 of the ADHD children twice: once when unmedicated, and once while taking methylphenidate (a stimulant medication commonly sold under brand names like Ritalin that works partly by boosting norepinephrine and dopamine signaling). The statistical model was built to account for age, IQ, and task difficulty so that differences in pupil variability would not simply reflect differences in cognitive ability.
This approach builds on a broader push to capture ADHD through eye physiology rather than behavior alone. AI-based eye-tracking tools for ADHD screening have shown that tablet-deployable systems can reliably distinguish eye movement patterns between children with and without ADHD, suggesting that the underlying technology is becoming accessible enough for real-world use.
What Medication Did to the Pupils
When the 17 ADHD children completed the task while medicated, their pupil response patterns shifted noticeably: responses grew stronger overall and fluctuated less between trials, moving closer to the patterns seen in the neurotypical control group. This is an intriguing finding, but the researchers are careful not to overinterpret it. Yadav noted explicitly that "we would not interpret this as evidence that medication 'normalized' attention. We could not completely separate these pharmacological effects from cognitive effects."
That caution is warranted. Methylphenidate affects multiple physiological systems simultaneously, including those that directly govern pupil diameter, so it is not possible to know from this data whether better pupil consistency reflects better attention regulation or a more direct drug effect on the pupillary reflex itself.
Key Limitations That Matter for Anyone Reading This
The study is small, uses pre-existing data collected in a lab environment, and was conducted in a single geographic cohort. Individual comparisons between participants for variability narrowly missed statistical significance, and the link between pupil variability and lower accuracy was not significantly stronger in the ADHD group than in controls. The two medication-phase sessions were six months apart, which means maturation or practice could account for some of the observed changes.
Previous pupillometry work, including a study on adult ADHD and alertness regulation that found suppressed phasic pupil dilation in adults with ADHD, suggests the signal extends beyond childhood, but it also underlines how much the pupil response depends on baseline arousal state, time of day, caffeine, and dozens of other variables that are hard to standardize in a clinical setting. Yadav put it plainly: "It is still too early to consider pupil measurements as a clinical diagnostic tool."
What Comes Next in Pupil-Based ADHD Research
The next steps are larger independent samples, diverse environments beyond a controlled lab, and longer follow-up periods to separate developmental change from medication effects. Researchers also need to establish how much pupil variability fluctuates naturally in a given child day to day, because a marker that shifts too easily with sleep quality or anxiety would be hard to use reliably.
If those studies replicate the core finding, eye-tracking could eventually join a panel of complementary measures used alongside behavioral rating scales, not as a standalone test, but as a physiological data point that makes the overall picture more complete.
Common Questions
Can a doctor use this to diagnose my child with ADHD? Not yet. This is early-stage research on 50 children from a single study. It is not validated as a clinical tool, and no eye-tracking test for ADHD is currently approved for routine diagnostic use.
Does this mean ADHD is visible in the eyes? The pupils are reflecting brain activity related to arousal and attention, not ADHD itself. Many factors affect pupil size, including light, fatigue, caffeine, and anxiety. A single pupil measurement would not tell a clinician much; it is the pattern of variability across many trials that carries the potential signal.
Should I ask about methylphenidate if my child's attention is inconsistent? That is a conversation for your child's doctor, who can weigh the full clinical picture. This study cannot tell you whether medication will help any individual child; it only shows that, on average, a group of medicated children showed different pupil patterns than the same children when unmedicated.
Evidence Rating
INVESTIGATIONAL — 55/100
Caveats
- Small reanalysis of pre-existing data (n=50 children); results should be considered preliminary.
- Direct between-participant comparisons narrowly missed statistical significance after multiple-test correction.
- The medication sub-study (n=17) cannot separate methylphenidate’s direct pharmacological effects on pupil physiology from any cognitive improvement.
- Not yet suitable as a clinical diagnostic tool; larger independent studies in naturalistic settings are needed.
This study is a reanalysis of existing eye-tracking data from 50 children (28 with ADHD, 22 controls) examining trial-to-trial pupil response variability as a potential physiological correlate of attention. It reports a 23% greater variability estimate in unmedicated ADHD children, though direct between-participant comparisons narrowly missed corrected statistical significance. The cross-sectional reanalysis design, small sample, single-site cohort, and absence of independent replication limit the generalizability of findings.
References
- Saumya Yadav, Aadya, Jainendra Shukla (2026). Trial-level pupil dynamics reflect attention-related variability and medication-associated modulation in ADHD. Scientific Reports. https://doi.org/10.1038/s41598-026-68871-2
- Ayumu Ueno, Sou Nobukawa, Aya Shirama (2025). Multimodal biomarker based on temporal complexity of eye movements and pupil diameter in attention-deficit/hyperactivity disorder. PLOS Mental Health. https://doi.org/10.1371/journal.pmen.0000456
- Giorgia Michelini, Luke J. Norman, Philip Shaw, Sandra K. Loo (2022). Treatment biomarkers for ADHD: Taking stock and moving forward. Translational Psychiatry. https://doi.org/10.1038/s41398-022-02207-2
- Xiaolu Chen, Sihan Wang, Xiaowen Yang, et al. (2023). Utilizing artificial intelligence-based eye tracking technology for screening ADHD symptoms in children. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2023.1260031
- Aya Shirama, Toshinobu Takeda, Haruhisa Ohta, Akira Iwanami, Shigenobu Toda, Nobumasa Kato (2020). Atypical alert state control in adult patients with ADHD: A pupillometry study. PLOS ONE. https://doi.org/10.1371/journal.pone.0244662